Literature DB >> 18684023

The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review.

Kathleen T Montone1, Zubair W Baloch, Virginia A LiVolsi.   

Abstract

CONTEXT: Hürthle cells are eosinophilic, follicular-derived cells that are associated with a variety of nonneoplastic and neoplastic thyroid lesions. The differential diagnosis of Hürthle cell lesions is quite broad.
OBJECTIVE: To review the pathologic conditions associated with Hürthle cells in the thyroid and to discuss pathology of thyroid lesions associated with oncocytic cytology. DATA SOURCES: A variety of thyroid nonneoplastic (autoimmune thyroiditis, multinodular goiter) and neoplastic conditions (Hürthle cell adenoma, Hürthle cell carcinoma) are associated with Hürthle cell cytology. In addition, there are several thyroid neoplasms that should be considered when one observes a Hürthle cell neoplasm in the thyroid (oncocytic variant of medullary carcinoma, several variants of papillary thyroid carcinoma).
CONCLUSIONS: Oncocytic cytology is seen in a variety of thyroid conditions that are associated with a broad differential diagnosis and care must be used for accurate diagnosis. Newer molecular-based techniques may be useful for further classification of thyroid neoplasms with oncocytic pathology.

Entities:  

Mesh:

Year:  2008        PMID: 18684023     DOI: 10.5858/2008-132-1241-TTHOCA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  35 in total

1.  PVALB, a new Hürthle adenoma diagnostic marker identified through gene expression.

Authors:  Janete M Cerutti; Gisele Oler; Rosana Delcelo; Rene Gerardt; Pedro Michaluart; Sandro J de Souza; Pedro A F Galante; Peng Huang; Gregory J Riggins
Journal:  J Clin Endocrinol Metab       Date:  2010-10-06       Impact factor: 5.958

Review 2.  Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.

Authors:  Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

3.  Current concepts and future directions in differentiated thyroid cancer.

Authors:  Donald S A McLeod
Journal:  Clin Biochem Rev       Date:  2010-02

Review 4.  Papillary carcinoma tall cell variant (TCV): a review.

Authors:  Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

5.  Images in endocrine pathology: psammomatoid calcifications in oncocytic neoplasms of the thyroid, a potential pitfall for papillary carcinoma.

Authors:  Marc P Pusztaszeri; Peter M Sadow; William C Faquin
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

Review 6.  Hurthle Cell Lesion: Controversies, Challenges, and Debates.

Authors:  Michael Shawky; Mahmoud Sakr
Journal:  Indian J Surg       Date:  2015-10-30       Impact factor: 0.656

7.  MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.

Authors:  Katayoon Kasaian; Ana-Maria Chindris; Sam M Wiseman; Karen L Mungall; Thomas Zeng; Kane Tse; Jacqueline E Schein; Michael Rivera; Brian M Necela; Jennifer M Kachergus; John D Casler; Andrew J Mungall; Richard A Moore; Marco A Marra; John A Copland; E Aubrey Thompson; Robert C Smallridge; Steven J M Jones
Journal:  J Clin Endocrinol Metab       Date:  2015-01-27       Impact factor: 5.958

Review 8.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

9.  Warthin tumor-like papillary thyroid carcinoma with a minor dedifferentiated component: report of a case with clinicopathologic considerations.

Authors:  Paolo Amico; Salvatore Lanzafame; Giovanni Li Destri; Paolo Greco; Rosario Caltabiano; Giada Maria Vecchio; Gaetano Magro
Journal:  Case Rep Med       Date:  2010-06-07

10.  Immunoproteasome overexpression underlies the pathogenesis of thyroid oncocytes and primary hypothyroidism: studies in humans and mice.

Authors:  Hiroaki J Kimura; Cindy Y Chen; Shey-Cherng Tzou; Roberto Rocchi; Melissa A Landek-Salgado; Koichi Suzuki; Miho Kimura; Noel R Rose; Patrizio Caturegli
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.